Patient's choice of observational strategy for early-stage prostate cancer

Neuropsychological Trends

Volumn 12, Issue 1, 2012, Pages 107-116

  Bellardita, Lara ^a   Graffigna, Guendalina ^b   Donegani, Simona ^a   Villani, Daniela ^b   Villa, Silvia ^a   Tresoldi, Veronica ^a   Marenghi, Cristina ^a   Magnani, Tiziana ^a   Valdagni, Riccardo ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITÀ CATTOLICA DEL SACRO CUORE   (Italy)

Author keywords

Active surveillance; Choice; Patient's engagement.; Prostate cancer

Indexed keywords

EID: 84876338912     PISSN: 1970321X     EISSN: 19703201     Source Type: Journal    
DOI: 10.7358/neur-2012-012-bell     Document Type: Article

References (33)

1. Associazione Italiana dei Registri Tumori & Associazione Italiana di Oncologia Medica (2011). I numeri del cancro in Italia 2011. Brescia: Intermedia.
2. Barello, S., Graffigna, G.,&Vegni, E. (2012). Patient engagement asan emerging challenge for health-care services: mapping the literature by bibliometric analysis. Nursing Research and Practice (online publication ahead of print).
3. Bellardita, L., Donegani, S., Spatuzzi, A.L.,&Valdagni, R. (2011). Multidiscipli-nary versus one-on-one setting: a qualitative study of clinicians' perceptions of their relationship with patients with prostate cancer. Journal of Oncology Practice / American Society of Clinical Oncology, 7 (1), 1-5.
4. Bul, M., van den Bergh, R.C., Rannikko, A., Valdagni, R., Pickles, T., Bangma, C.H.,&Roobol, M.J. (2012). Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program. European Urology, 61 (2), 370-377.
5. Burnet, K.L., Parker, C., Dearnaley, D., Brewin, C.R.,&Watson, M. (2007). Does active surveillance for men with localized prostate cancer carry psychological morbidity? BJU International, 100 (3), 540-543.
6. Cohen, H.,&Britten, N. (2003). Who decides about prostate cancer treatment? A qualitative study. Family Practice, 20 (6), 724-729.
7. Cooperberg, M.R., Carroll, P.R.,&Klotz, L. (2011). Active surveillance for prostate cancer: progress and promise. Journal of Clinical Oncology / Official Journal of the American Society of Clinical Oncology, 29 (27), 3669-3676.
8. Coulter, A. (2010). Do patients want a choice and does it work? BMJ, 341 (7780), 973-975.
9. Davison, B.J., Oliffe, J.L., Pickles, T.,&Mroz, L. (2009). Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncology Nursing Forum, 36 (1), 89-96.
10. Davison, B.J., So, A.I.,&Goldenberg, S.L. (2007). Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer. BJU International, 100 (4), 780-785.
11. Ferlay, J., Parkin, D.M.,&Steliarova-Foucher, E. (2010). Estimates of cancer incidence and mortality in Europe in 2008. European Journal of Cancer, 46 (4), 765-781.
12. Gambetti, R.,&Graffigna, G. (2010). Exploring the concept of engagement in market research: a systematic analysis of the ongoing debate. International Journal of Marketing Research, 52 (6), 801-826.
13. Gilardi, S.,&Lozza, E. (2009). Inquiry-based learning and undergraduates' professional identity development: assessment of a field research-based course. Innovative Higher Education, 34 (4), 245-256.
14. Goh, A.C., Kowalkowski, M.A., Bailey, D.E. Jr., Kazer, M.W., Knight, S.J.,&Latini, D.M. (2011). Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. BJU International, 110 (2b), E50-56.
15. Gorin, M.A., Soloway, C.T., Eldefrawy, A.,&Soloway, M.S. (2011). Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology, 77 (3), 588-591.
16. Graffigna, G., Vegni, E., Barello, S., Olson, K.,&Bosio, A.C. (2011). Studying the social construction of cancer-related fatigue experience: the heuristic value of Ethnoscience. Patients Education and Counselling, 82, 402-409.
17. Gruman, J., Rovner, M.H., French, M.E., Jeffres, D., Sofaer, S., Shaller. D.,&Prager, D.J. (2010). From patient education to patient engagement: implications for the field of patient education. Patient Education and Counseling, 78, 350-356.
18. Hamdy, F.C. (2011). Long-term quality of life in prostate cancer. The Lancet Oncology, 12 (9), 832-833.
19. Heidenreich, A., Bellmunt, J., Bolla, M., Joniau, S., Mason, M., Matveev, V.,&Zattoni, F. (2011). EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. European Urology, 59 (1), 61-71.
20. Hibbard, J.H., Stockard, J., Mahoney, E.R.,&Tusler, M. (2004). Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Services Research, 39, 1005-1026.
21. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T.,&Thun, M.J. (2008). Cancer statistics. CA: A Cancer Journal for Clinicians, 58 (2), 71-96.
22. Klotz, L. (2012). Active surveillance for favorable-risk prostate cancer: background, patient selection, triggers for intervention, and outcomes. Current Urology Reports, 13 (2), 153-159.
23. Magnani, T., Valdagni, R., Salvioni, R., Villa, S., Bellardita, L., Donegani, S.,&Zaffaroni, N. (2012). The 6-year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes. BJU International, 110 (7), 998-1003.
24. Mauri, E., Vegni, E., Lozza, E., Parker, P.A.,&Moja, E.A. (2009). An exploratory study on the Italian patients' preferences regarding how they would like to be told about their cancer. Supportive Care in Cancer, 17 (12), 1523-1530.
25. O'Connor, A.M., Bennett, C.L., Stacey, D., Barry, M., Col, N.F., Eden, K.B., Entwistle, V.A., Fiset, V., Holmes-Rovner, M., Khangura, S., Llewellyn-Thomas, H., Rovner, D. (2009). Decision aids for people facing health treatment or screening decisions. Cochrane Database Systematic Reviews, 8 (3), CD001431.
26. Pickles, T., Ruether, J.D., Weir, L., Carlson, L., Jakulj, F. ,&SCRN Communication Team (2007). Psychosocial barriers to active surveillance for the management of early prostate cancer and a strategy for increased acceptance. BJU International, 100 (3), 544-551.
27. Valdagni, R. (2011). Prostate cancer units: has the time come to discuss this thorny issue and promote their establishment in Europe? European Urology, 60 (6), 1193-1196.
28. Van den Bergh, R.C., Essink-Bot, M.L., Roobol, M.J., Schroder, F.H., Bangma, C.H.,&Steyerberg, E.W. (2010). Do anxiety and distress increase during active surveillance for low risk prostate cancer? The Journal of Urology, 183 (5), 1786-1791.
29. Van den Bergh, R.C., Essink-Bot, M.L., Roobol, M.J., Wolters, T., Schroder, F.H., Bangma, C.H.,&Steyerberg, E.W. (2009). Anxiety and distress during active surveillance for early prostate cancer. Cancer, 115 (17), 3868-3878.
30. Van den Bergh, R.C., Korfage, I.J.,&Bangma, C.H. (2012). Psychological aspects of active surveillance. Current Opinion in Urology, 22 (3), 237-242.
31. Van den Bergh, R.C., Steyerberg, E.W., Khatami, A., Aus, G., Pihl, C.G.,&Wolters, T. (2010). Swedish and Dutch sections of the European randomized study of screening for prostate cancer. Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer, 116 (5), 1281-1290.
32. Van den Bergh, R.C., Vasarainen, H., van der Poel, H.G., Vis-Maters, J.J., Rietber-gen, J.B., Pickles, T., et al. (2010). Short-term outcomes of the prospective multicentre "Prostate Cancer Research International: Active Surveillance" study. BJU International, 105 (7), 956-962.
33. Vasarainen, H., Lokman, U., Ruutu, M., Taari, K.,&Rannikko, A. (2011). Prostate cancer active surveillance and health-related quality of life: results of the finnish arm of the prospective trial. BJU International, 109 (11), 1614-1619.